Key result
Mitral valvuloplasty in dogs with myxomatous mitral valve disease significantly altered myocardial deformation, with left ventricular global longitudinal strain changing from -24.4% preoperatively to -16.3% at 3 months.
Why the study?
Mitral valvuloplasty addresses regurgitation in dogs with myxomatous mitral valve disease, but pre- and postoperative changes in myocardial function remain uncertain.
Does mitral valvuloplasty improve myocardial function assessed by 2D-STE in dogs with myxomatous mitral valve disease?
Observational (n=8)
No
Does mitral valvuloplasty improve myocardial function assessed by 2D-STE in dogs with myxomatous mitral valve disease?
Absolute Event Rate: -16.3% vs -24.4%
p-value: p=0.015
In dogs with myxomatous mitral valve disease, mitral valvuloplasty improves left ventricular twisting motion and normalizes myocardial strain parameters.
Background Myxomatous mitral valve disease (MMVD) is the most common acquired heart disease in dogs. Mitral valvuloplasty (MVP) addresses regurgitation, but the pre- and postoperative changes in myocardial function remain uncertain. Objectives This study evaluated myocardial motion before and after MVP using two-dimensional speckle-tracking echocardiography (2D-STE). Animals Eight client-owned dogs undergoing MVP for MMVD. Methods Myocardial deformation was assessed by 2D-STE before surgery and at 1- and 3-months post-surgery. Measurements included left ventricular global longitudinal strain (GLS), global circumferential strain (GCS), global radial strain (GRS), cardiac twist, and right ventricular free wall GLS (RVFW-GLS). Results Postoperative decreases were observed in left ventricular internal dimensions, left atrial size, and early diastolic myocardial velocity, with an increase in peak late diastolic velocity. LV-GLS decreased at 1 month (−14.4%) and 3 months (−16.3%) compared to preoperative values (−24.4%) (p = 0.0078, p = 0.015). GCS decreased at 1 month (−12.9%) and 3 months (−14.8%) compared to preoperative values (−21.7%) (p = 0.0078). GRS decreased at 1 month (27.7%) and 3 months (32.0%) compared to preoperative values (67.7%) (p = 0.0078). No significant changes were observed in RVFW-GLS. Peak systolic twist increased at 3 months (9.1° vs. 4.9°, p = 0.039). Peak systolic apical rotation showed an upward trend at 3 months (p = 0.109). Left ventricular twist was mildly affected by LVIDd, LVIDDN, and sphericity index (R2 = 0.187, p = 0.034; R2 = 0.33, p = 0.0029; R2 = 0.22, p = 0.019). Conclusions and clinical importance Postoperative myocardial motion approached reference values, indicating significant improvement, particularly in left ventricular twisting motion. These findings highlight the positive impact of surgery on cardiac function in dogs with MMVD.
No takes yet. Share an insight, caveat, or question.
Fukuzumi et al. (2024) conducted an observational in Myxomatous mitral valve disease (MMVD) (n=8). Mitral valvuloplasty vs. Preoperative baseline was evaluated on Left ventricular global longitudinal strain (LV-GLS) at 3 months (p=0.015). Mitral valvuloplasty in dogs with myxomatous mitral valve disease significantly altered myocardial deformation, with left ventricular global longitudinal strain changing from -24.4% preoperatively to -16.3% at 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: